Guru Ownership Trend
Guru Analysis for Viking Therapeutics, Inc. (VKTX)
Viking Therapeutics, Inc. (VKTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $29.04 M.
Top institutional holders include Steven Cohen and Joel Greenblatt.
Institutional sentiment is currently Bullish. This is evidenced by a $30.24 M net inflow during the quarter.
Recent activity highlights Cliff Asness who dramatically increased their stake. Conversely, Joel Greenblatt reduced exposure by 11.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Viking Therapeutics, Inc. (VKTX)
Major holders include Steven Cohen ($18.46 M), Joel Greenblatt ($9 M), Cliff Asness ($7.84 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.24 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited VKTX. The total reported sell value was $1.17 M.
Yes, 1 managers opened new positions in VKTX, and 3 increased their existing holdings. The total reported buy value was $31.41 M.